1. Canada Stocks

  2. •

    Healthcare

  3. •

    Drug Manufacturers - Specialty & Generic
CENTR Brands Corp.

CENTR Brands Corp.

CNTR.CN
CENTR Brands Corp.CA flagCanadian Securities Exchange
0.03
CAD
+0.01
- -
347,932.00Market Cap
CENTR Brands Corp.
CNTR.CN
(Canadian Securities Exchange)

Recent

price

0.03

P/E

ratio

- -

div

yld

- -

ROIC.AI

2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
TTM
FRC
- -
- -
- -
- -
- -
- -
- -
- -
- -
0.11
0.14
0.31
- -
- -
- -
- -
Revenue per Share
-0.05
-0.15
-0.24
-0.01
-0.03
-0.01
-0.03
-0.04
- -
-0.6
-2.61
0.08
-1.2
-0.2
-0.04
-0.04
Basic EPS, GAAP
-0.01
-0.21
-0.03
-0.02
-0.03
- -
- -
- -
- -
-0.55
-0.77
-0.93
-0.25
-0.27
-0.01
-0.02
Free Cash Flow per Basic Share
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Dividend per Share
- -
-0.27
-0.32
-0.23
-0.26
-0.27
-0.07
-0.11
- -
-0.01
-1.13
0.46
-0.12
-0.29
-0.32
-0.35
Book Value per Share
- -
-0.02
0.02
- -
-0.02
-0.04
-0.07
-0.11
- -
0.09
-0.66
0.68
0.15
-0.11
-0.15
-0.16
Tangible Book Value per Share
1
- -
2
2
2
2
2
2
- -
6
7
8
8
12
12
11
Basic Weighted Avg Shares
- -
- -
- -
- -
- -
- -
- -
- -
- -
1
1
2
- -
- -
- -
- -
Sales/Revenue/Turnover
- -
- -
- -
- -
- -
- -
- -
- -
- -
-564.08
-821.09
-290.17
- -
- -
- -
- -
Operating Margin (%)
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Depreciation Expense
- -
- -
- -
- -
- -
- -
- -
- -
- -
-4
-17
1
-10
-2
- -
- -
Net Income, GAAP
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Effective Tax Rate (%)
- -
- -
- -
- -
- -
- -
- -
- -
- -
-564.01
-1,869.66
26.16
- -
- -
- -
- -
Profit Margin (%)
- -
- -
- -
- -
- -
- -
- -
- -
2
1
1
6
3
-1
-2
-2
Working Capital
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
LT Debt
- -
- -
- -
- -
- -
- -
- -
- -
2
1
-4
5
1
-1
-2
-2
Total Equity
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
-939.61
- -
- -
- -
- -
Return on Invested Capital (%)
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Return on Capital (%)
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Return on Common Equity (%)

Capital Structure

FRC

•

in mil. unless spec.
Aug'25
Nov'25
May'25
ST Debt
- -
- -
- -
LT Borrowings
- -
- -
- -
LT Finance Leases
- -
- -
- -
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
12
12
12
Market Capitalization
2
1
- -

Working Capital

FRC

•

in mil. unless spec.
Aug'25
Nov'25
May'25
Total Current Assets
- -
- -
- -
Cash, Cash Equivalents & STI
- -
- -
- -
Accounts Receivable, Net
- -
- -
- -
Inventories
- -
- -
- -
Total Current Liabilities
2
2
2
Payables & Accruals
1
1
2
ST Debt
- -
- -
- -
Deferred Revenue
- -
- -
- -

Growth Rates

FRC

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
-223.46%
-280.49%
33.15%
Free Cash Flow
- -
-3.33%
-94.56%
Net Income, GAAP
- -
-314.24%
-81.48%
Sales/Revenue/Turnover
- -
- -
- -
Total Cash Common Dividend
- -
- -
- -

Quarterly Revenue

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
- -
- -
- -
-1
- -
2025
- -
- -
- -
- -
- -
2026
- -
- -
- -
- -
- -

Quarterly Earnings Per Share

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
0.01
-0.17
-0.04
- -
-0.2
2025
-0.01
-0.02
-0.01
- -
-0.04
2026
-0.01
- -
- -
- -
- -

Quarterly Dividends Per Share

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
- -
- -
- -
- -
- -
2025
- -
- -
- -
- -
- -
2026
- -
- -
- -
- -
- -
Similar Companies
Yuyu Pharma, Inc. (000225.KS)
Sandoz Group AG (SDZ.SW)
Heilongjiang ZBD Pharmaceutical Co., Ltd. (603567.SS)
Cipher Pharmaceuticals Inc. (CPHRF)
Perrigo Company plc (PRGO)
Cosmos Health Inc. (COSM)
Business
CENTR Brands Corp. (CSE: CNTR), founded in 2012 and headquartered in Vancouver, British Columbia, Canada, develops, manufactures, markets and distributes non-alcoholic functional wellness beverages infused with hemp-derived cannabidiol (CBD) extracts and derivatives, as well as non-CBD enhanced sparkling waters; its core product lines include CENTR CBD sparkling beverages in regular and sugar-free variants at 30mg CBD per can, CENTR Enhanced zero-calorie functional sparkling waters targeting gut health and cognitive performance, CENTR Enhanced+, CENTR Instant drink mix powders in Balance, Recover and Relax formulas with electrolytes, antioxidants, adaptogens and vitamins, and CENTR Unsweetened; the company targets health-conscious consumers seeking relaxation, recovery and balance through innovative, low-calorie formulations and operates primarily in North America via retail channels, distributors such as KeHE, online platforms including Amazon.com, and select partnerships. In recent developments, CENTR Brands implements a ten-for-one share consolidation effective November 18, 2024 to enhance financing flexibility and strategic pursuits; it appoints Campbell Becher as chief executive officer and Jeffrey Holmgren to the board in March 2024, alongside Anton Drescher as interim chief financial officer in January 2024; the company ceased funding its USA-based CBD business unit in December 2023, terminated most employees except the then-CEO and shifted focus to non-CBD products like CENTR Enhanced with US expansion and potential Canadian entry; earlier changes encompass leadership transitions including Arjan Chima's added president role in November 2023, termination of the Southern Glazer's distribution agreement in October 2023 due to their CBD category exit, launch of CENTR Enhanced on Amazon in September 2023 with strong distributor sales growth, and expanded media partnerships such as with OpTic Gaming in November 2023.